We are live on ! Find out more
LMAT icon

LeMaitre Vascular

189 hedge funds and large institutions have $971M invested in LeMaitre Vascular in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 72 increasing their positions, 61 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 13

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

18% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 61

10% more capital invested

Capital invested by funds: $879M → $971M (+$92.1M)

6% more funds holding

Funds holding: 179189 (+10)

0.59% less ownership

Funds ownership: 87.86%87.27% (-0.59%)

Holders
189
Holders Change
+10
Holders Change %
+5.59%
% of All Funds
3.26%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
24
Increased
72
Reduced
61
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Envestnet Asset Management
26
Envestnet Asset Management
Illinois
$8.85M +$104K +2,086 +1%
Comerica Bank
27
Comerica Bank
Texas
$8.47M -$125K -2,504 -1%
ProShare Advisors
28
ProShare Advisors
Maryland
$8.14M -$1.18M -23,596 -13%
Charles Schwab
29
Charles Schwab
California
$7.91M +$124K +2,472 +2%
Victory Capital Management
30
Victory Capital Management
Texas
$7.79M -$761K -15,227 -9%
Principal Financial Group
31
Principal Financial Group
Iowa
$6.25M -$351K -7,034 -5%
N
32
Nuveen
North Carolina
$5.54M -$84.2K -1,684 -2%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$5.43M +$104K +2,084 +2%
Invesco
34
Invesco
Georgia
$4.81M +$127K +2,540 +3%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$4.79M -$113K -2,271 -2%
CVA
36
Ceredex Value Advisors
Florida
$4.63M -$89.3K -1,787 -2%
CIC
37
Crawford Investment Counsel
Georgia
$4.51M +$78K +1,560 +2%
Goldman Sachs
38
Goldman Sachs
New York
$4.38M -$2.01M -40,233 -32%
BCC
39
Bridge City Capital
Oregon
$3.74M +$124K +2,489 +3%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$3.21M -$80K -1,600 -2%
Janus Henderson Group
41
Janus Henderson Group
United Kingdom
$3.17M +$1.55M +31,084 +99%
Renaissance Technologies
42
Renaissance Technologies
New York
$2.68M -$205K -4,100 -7%
Stifel Financial
43
Stifel Financial
Missouri
$2.52M -$46.6K -932 -2%
State of New Jersey Common Pension Fund D
44
State of New Jersey Common Pension Fund D
New Jersey
$2.4M -$165K -3,298 -7%
Swiss National Bank
45
Swiss National Bank
Switzerland
$2.37M +$15K +300 +0.6%
Legal & General Group
46
Legal & General Group
United Kingdom
$2.34M +$21.3K +426 +0.9%
Citadel Advisors
47
Citadel Advisors
Florida
$2.17M +$1.45M +29,049 +212%
Wells Fargo
48
Wells Fargo
California
$2.11M +$2.35K +47 +0.1%
VFA
49
Values First Advisors
Tennessee
$2.01M +$51K +1,021 +3%
PCM
50
Perkins Capital Management
Minnesota
$1.97M +$1.94M +38,900 New

LMAT Hedge Fund Activity: Q3 2022 in Review

189 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2022, worth a combined $971M — up 10% from $879M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new LMAT positions and 13 closed out — a net gain of 11 holders — while 72 added to existing stakes and 61 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $3.21M. The largest seller was Summit Creek Advisors, cutting an estimated $6.38M.

  • 189 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2022, up from 179 in Q2 2022.
  • Funds reported $971M of LeMaitre Vascular stock for Q3 2022, up 10% quarter-over-quarter.
  • 24 funds opened new LeMaitre Vascular positions in Q3 2022 and 13 closed out, a net change of +11 holders.
  • The largest LeMaitre Vascular buyer in Q3 2022 was VOYA Investment Management, an estimated $3.21M added.
  • The largest LeMaitre Vascular seller in Q3 2022 was Summit Creek Advisors, an estimated $6.38M sold.

Based on aggregated 13F filings for Q3 2022.